Compared to the 1-P-only group, SIRT1 overexpression increased HCC cell viability, restored clonogenic capacity, reduced apoptosis, modulated apoptotic protein expression, rescued ΔΨm decline, and mitigated cell cycle perturbations. The gene discussed is SIRT1; the disease is hepatocellular carcinoma.